U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
165391165391NeuroPath Comparative Validation Study PlanTerminatedNo Results AvailableCarpal Tunnel Syndrome (CTS)Device: NeuroPathhttps://ClinicalTrials.gov/show/NCT00393549
165392165392Study of Whether Educational Visits to Primary Care Professionals Improves the Quality of Care They Provide.CompletedNo Results AvailableDepressionBehavioral: Educational outreach visitinghttps://ClinicalTrials.gov/show/NCT00393536
165393165393Hepatitis B Vaccine Booster Study (V232-058)CompletedHas ResultsHepatitis BBiological: Comparator: Modified Process Hepatitis B Vaccine|Biological: Comparator: Comparator: ENGERIX-Bhttps://ClinicalTrials.gov/show/NCT00393523
165394165394Herbal Preparation Used as Adjuvant Therapy on Diabetic UlcersCompletedHas ResultsDiabetic Foot Ulcer|AmputationDrug: TCM|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00393510
165395165395A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer TreatmentCompletedNo Results AvailableBreast Cancer|LymphedemaDrug: bevacizumabhttps://ClinicalTrials.gov/show/NCT00393497
165396165396A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B InfectionCompletedHas ResultsChronic Hepatitis BDrug: Entecavir|Drug: Lamivudine Placebo|Drug: Lamivudine|Drug: Entecavir Placebohttps://ClinicalTrials.gov/show/NCT00393484
165397165397Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.CompletedNo Results AvailableActive Rheumatoid ArthritisDrug: Etanercepthttps://ClinicalTrials.gov/show/NCT00393471
165398165398Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active ControlCompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: Indacaterol|Drug: Formoterol|Drug: Placebo to indacaterol|Drug: Placebo to formoterolhttps://ClinicalTrials.gov/show/NCT00393458
165399165399Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in HumansCompletedNo Results AvailableHyperglycemiaDrug: GLP-1 control|Drug: GLP-1 and Exendin(9-39) 300|Drug: saline control|Drug: GLP-1 and Exendin(9-39) 600|Drug: GLP-1 and Exendin(9-39) 900|Drug: GLP-1 and Exendin(9-39) 1200https://ClinicalTrials.gov/show/NCT00393445
165400165400Enhancing Motor Task Training by Action Observation Watching Others Perform the TaskCompletedNo Results AvailableMotor Memoryhttps://ClinicalTrials.gov/show/NCT00393432
165401165401Federal Study of Adherence to Medications in the Elderly (FAME)CompletedNo Results AvailableMedication Adherence|Hypertension|HyperlipidemiaBehavioral: Comprehensive pharmacy care programhttps://ClinicalTrials.gov/show/NCT00393419
165402165402The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method ApproachCompletedNo Results AvailableBreast Neoplasmshttps://ClinicalTrials.gov/show/NCT00393406
165403165403Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the KneeRecruitingNo Results AvailableOsteoarthritisDrug: intra-articular injection of Hylan G-F 20https://ClinicalTrials.gov/show/NCT00393393
165404165404Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated DonorTerminatedHas ResultsLeukemia, Myeloid, Chronic|Anemia, Aplastic|Myelofibrosis|Lymphoma|Hodgkin Disease|Leukemia, Lymphocytic, Chronic|Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, AcuteDrug: Parathyroid Hormone (teriparatide)https://ClinicalTrials.gov/show/NCT00393380
165405165405Budesonide Inhalation Suspension for Acute Asthma in ChildrenCompletedHas ResultsAsthma|Acute Asthma|Reactive Airway ExacerbationDrug: Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg|Drug: Prednisolone, prednisone, or methylprednisolone|Drug: Albuterol, ipratropium bromide|Drug: Ipratropium bromidehttps://ClinicalTrials.gov/show/NCT00393367
165406165406Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)CompletedNo Results AvailableRecurrent Low Back PainDrug: MK0663, Etoricoxib / Duration of Treatment : 12 Weeks|Drug: Comparator : placebo (unspecified) /Duration of Treatment : 12 Weekshttps://ClinicalTrials.gov/show/NCT00393354
165407165407Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast CancerCompletedNo Results AvailableBreast Cancer Stage IV|Breast Cancer Stage I|Breast Cancer Stage IIProcedure: Blood Drawhttps://ClinicalTrials.gov/show/NCT00393341
165408165408Bioequivalence Study of Atazanavir 300 mg CapsuleCompletedNo Results AvailableHIV InfectionsDrug: Atazanavir + Ritonavir|Drug: Atazanavir + Ritonavirhttps://ClinicalTrials.gov/show/NCT00393328
165409165409P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent RestenosesCompletedNo Results AvailableIn-Stent RestenosisDevice: paclitaxel coated balloon catheterhttps://ClinicalTrials.gov/show/NCT00393315
165410165410HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing StrategyCompletedNo Results AvailableHIV|AIDS Virus|PregnancyProcedure: HIV screening in pregnancyhttps://ClinicalTrials.gov/show/NCT00393302
165411165411Calcium Absorption and Retention From Marine ProductsActive, not recruitingNo Results AvailableCalcium MetabolismBehavioral: Calcium controlled diethttps://ClinicalTrials.gov/show/NCT00393289
165412165412Determining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsCompletedNo Results AvailableHIV Infections|Hepatitis CBiological: Twinrix|Biological: Decavachttps://ClinicalTrials.gov/show/NCT00393276
165413165413Clobetasol Versus Pimecrolimus for Vulvar Lichen SclerosusCompletedNo Results AvailableLichen SclerosusDrug: pimecrolimus and clobetasol|Drug: clobetasol 0.05% creamhttps://ClinicalTrials.gov/show/NCT00393263
165414165414Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell DiseaseCompletedNo Results AvailableSickle Cell DiseaseBehavioral: Hypnosishttps://ClinicalTrials.gov/show/NCT00393250
165415165415Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC FamiliesCompletedNo Results AvailableNasopharyngeal Carcinomahttps://ClinicalTrials.gov/show/NCT00393224
165416165416Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)CompletedNo Results AvailableRecurrent Low Back PainDrug: MK0663, Etoricoxib / Duration of Treatment : 12 Weeks|Drug: Comparator : placebo (unspecified) /Duration of Treatment : 12 Weekshttps://ClinicalTrials.gov/show/NCT00393211
165417165417Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of MenorrhagiaCompletedNo Results AvailableContraception|MenorrhagiaDrug: Levonorgestrel (Mirena, BAY86-5028)|Drug: Cytotec|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00393198
165418165418Stem Cell Transplantation in Patients With Primary Biliary CirrhosisWithdrawnNo Results AvailablePrimary Biliary CirrhosisBiological: Non-myeloablative Hematopoietic Stem Cell Transplantationhttps://ClinicalTrials.gov/show/NCT00393185
165419165419Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]CompletedNo Results AvailableBreast Cancer|ObesityBehavioral: exercisehttps://ClinicalTrials.gov/show/NCT00393172
165420165420The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in ChildrenRecruitingNo Results AvailableOtitis Media|Conductive Hearing LossDevice: Ear Popperhttps://ClinicalTrials.gov/show/NCT00393159

* Görseller ve İçerik tekif hakkına sahip olabilir